NPS PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
NPS PHARMACEUTICALS INC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $92.86 million as of 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2015-02-18
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $92.86M.
- 2014-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $62.09M.
- 2014-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $84.50M.
- 2014-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $72.99M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2014-12-31 | $92.86M 10-K · filed 2015-02-18 |
| 2014-09-30 | $62.09M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $84.50M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $72.99M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $63.69M 10-K · filed 2014-02-18 |
| 2013-09-30 | $79.72M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $32.14M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $21.20M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $14.69M 10-K · filed 2013-02-21 |